NCT02145767View on ClinicalTrials.gov

Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

850

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
MiscarriagePreterm Birth
Interventions
DRUG

Progesterone

DRUG

Placebo

Trial Locations (7)

N2H 5Z8

Karma Medical Clinic, Kitchener

Unknown

North York General Hospital, North York

CHU Sainte-Justine, Montreal

MUHC Royal Victoria Hospital, Montreal

St. Mary's Hospital, Montreal

H3T 1E2

Jewish General Hospital, Montreal

J1H 5N4

Hôpital Fleurimont, Sherbrooke

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Sir Mortimer B. Davis - Jewish General Hospital

OTHER

NCT02145767 - Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial | Biotech Hunter | Biotech Hunter